Tag: merger and acquisition
Gilead gets hold of innovative liver disease drug ...
Posted by Editor | Feb 13, 2024 | LATEST NEWS, Mergers, Investments & Funding, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
AbbVie expands IBD pipeline with US$138 M Landos acquisition
by Editor | Mar 26, 2024 | Diseases News, Government, Regulatory & Policy News, LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
USA—AbbVie, the sixth largest pharmaceutical company in sales and headquartered in North Chicago,...
Read MoreGSK completes US$1.4 B acquisition of Aiolos Bio
by Editor | Feb 19, 2024 | LATEST NEWS, WORLD NEWS | 0
USA – In a significant expansion of GSK’s respiratory biologics portfolio, the company has successfully concluded the acquisition of Aiolos Bio for a deal potentially reaching US$1.4 billion.
Read MoreGilead gets hold of innovative liver disease drug with US$4.3B acquisition of CymaBay
by Editor | Feb 13, 2024 | LATEST NEWS, Mergers, Investments & Funding, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
USA – Gilead Sciences is set to broaden its medical arsenal with the acquisition of CymaBay...
Read MoreAlembic Pharma acquires 100% stake in Aleor Dermaceuticals
by Editor | Mar 30, 2022 | Hospitals, LATEST NEWS, WORLD NEWS | 0
INDIA – Alembic Pharma has acquired the remaining 40% stake in Aleor Dermaceuticals from its joint...
Read More